Geriatric vision loss due to cataracts, macular degeneration, and glaucoma.
暂无分享,去创建一个
[1] S. Gedde,et al. Review of results from the Tube Versus Trabeculectomy Study , 2010, Current opinion in ophthalmology.
[2] David J. Apple,et al. Posterior capsule opacification. , 1992, Survey of ophthalmology.
[3] S. Fisher,et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.
[4] D. Apple,et al. Surgical prevention of posterior capsule opacification. Part 2: Enhancement of cortical cleanup by focusing on hydrodissection. , 2000, Journal of cataract and refractive surgery.
[5] J J Anderson,et al. Impaired Vision and Hip Fracture , 1989, Journal of the American Geriatrics Society.
[6] P. Rosenfeld,et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. , 2011, Ophthalmology.
[7] Denise S. Kim,et al. Differences in rates of glaucoma among Asian Americans and other racial groups, and among various Asian ethnic groups. , 2011, Ophthalmology.
[8] C. Margo,et al. Cataract Surgery Among Veterans 65 Years of Age and Older: Analysis of National Veterans Health Administration Databases , 2010, American journal of medical quality : the official journal of the American College of Medical Quality.
[9] N. Powe,et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. , 1994, Archives of ophthalmology.
[10] K. Hoffer. Biometry of 7,500 cataractous eyes. , 1980, American journal of ophthalmology.
[11] V. Ourednik,et al. Neural Stem/Progenitor Cells Initiate the Formation of Cellular Networks That Provide Neuroprotection by Growth Factor‐Modulated Antioxidant Expression , 2008, Stem cells.
[12] R. Guymer,et al. C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. , 2010, Ophthalmology.
[13] Douglas R. Anderson,et al. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.
[14] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[15] Kuldev Singh,et al. Early aggressive intraocular pressure lowering, target intraocular pressure, and a novel concept for glaucoma care. , 2008, Survey of ophthalmology.
[16] N. Mamalis,et al. Three‐year clinical comparison of 3‐piece AcrySof and SI‐40 silicone intraocular lenses , 2002, Journal of cataract and refractive surgery.
[17] K. Schulman,et al. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. , 2010, Archives of ophthalmology.
[18] D. R. Anderson,et al. Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. , 1989, American journal of ophthalmology.
[19] H. Hayashi,et al. Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome , 1998, The British journal of ophthalmology.
[20] T. Wong,et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. , 2008, Archives of ophthalmology.
[21] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[22] C. Sorenson,et al. Anti-vascular endothelial growth factor therapy and renal thrombotic microangiopathy. , 2011, Archives of ophthalmology.
[23] J. Menikoff,et al. Prophylaxis of endophthalmitis with topical povidone-iodine. , 1991, Ophthalmology.
[24] L. Leape,et al. The appropriateness of use of coronary artery bypass graft surgery in New York State. , 1993, JAMA.
[25] S. Masket,et al. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. , 2002, Ophthalmology.
[26] A. Sommer,et al. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. , 1995, The New England journal of medicine.
[27] C. Alpers,et al. VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.
[28] A. Reidy,et al. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial , 2001, The British journal of ophthalmology.
[29] R. Hitchings,et al. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. , 1994, Ophthalmology.
[30] M. Leyland,et al. Multifocal versus monofocal intraocular lenses in cataract surgery: a systematic review. , 2003, Ophthalmology.
[31] L. Aiello,et al. RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW , 2004, Retina.
[32] K. D. Eichenbaum,et al. Comparing dynamic contour tonometry to Goldmann and hand-held tonometry in normal, ocular hypertension, and glaucoma populations , 2007, Annals of ophthalmology.
[33] Paul P. Lee,et al. Longitudinal rates of cataract surgery. , 2006, Archives of ophthalmology.
[34] C. Lowder,et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. , 2011, Archives of ophthalmology.
[35] E. Halm,et al. Revisiting the Appropriateness of Carotid Endarterectomy , 2003, Stroke.
[36] P. Yoder,et al. Toric intraocular lens implantation: 100 consecutive cases , 2002, Journal of cataract and refractive surgery.
[37] R. Klein,et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. , 2001, American journal of epidemiology.
[38] Beth T. Stalvey,et al. Older drivers and cataract: driving habits and crash risk. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[39] M. Mulvihill,et al. The prevalence of eye disease in nursing home and non-nursing home geriatric populations. , 1999, Archives of gerontology and geriatrics.
[40] Chris A. Johnson,et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002 .
[41] B. Prum,et al. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration , 2000 .
[42] S. Asrani,et al. Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma , 2000, Journal of glaucoma.
[43] M. Tinetti,et al. Risk factors for falls among elderly persons living in the community. , 1988, The New England journal of medicine.
[44] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[45] E. E. Hartmann,et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.
[46] Glenn J Jaffe,et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.
[47] Britta Lundqvist,et al. Ten-year longitudinal visual function and Nd: YAG laser capsulotomy rates in patients less than 65 years at cataract surgery. , 2010, American journal of ophthalmology.
[48] R. Klein,et al. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. , 2005, Archives of ophthalmology.
[49] Young H. Kwon,et al. Novel drug delivery systems for glaucoma , 2011, Eye.
[50] G. Naumann,et al. Differential gene expression in pseudoexfoliation syndrome. , 2005, Investigative ophthalmology & visual science.
[51] R. E. Smith,et al. Propionibacterium acnes isolated from explanted intraocular lens in pseudophakic bullous keratopathy. , 1989, Cornea.
[52] R. Klein,et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.
[53] M. Kahook,et al. Assessment of bleb morphologic features and postoperative outcomes after Ex-PRESS drainage device implantation versus trabeculectomy. , 2011, American journal of ophthalmology.
[54] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[55] P. Gouras,et al. Drusenoid maculopathy in rhesus monkeys: autofluorescence, lipofuscin and drusen pathogenesis , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[56] S. West,et al. Epidemiology of risk factors for age-related cataract. , 1995, Survey of ophthalmology.
[57] M. C. Leske,et al. Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.
[58] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[59] S. Masket,et al. Late complications with intraocular lens dislocation after capsulorhexis in pseudoexfoliation syndrome. , 2002, Journal of cataract and refractive surgery.
[60] B. Nan,et al. Rates of nonexudative and exudative age-related macular degeneration among Asian American ethnic groups. , 2011, Investigative ophthalmology & visual science.
[61] C. Owsley,et al. Impact of cataract surgery on self‐reported visual difficulties: Comparison with a no‐surgery reference group , 2003, Journal of cataract and refractive surgery.
[62] T. Sheidow,et al. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. , 2007, Ophthalmology.
[63] R. Klein,et al. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. , 2002, American journal of epidemiology.
[64] Li Wang,et al. Effect of decentration of wavefront-corrected intraocular lenses on the higher-order aberrations of the eye. , 2005, Archives of ophthalmology.
[65] H. Jampel. Target pressure in glaucoma therapy. , 1997, Journal of glaucoma.
[66] Shan C. Lin,et al. Endoscopic and Transscleral Cyclophotocoagulation for the Treatment of Refractory Glaucoma , 2008, Journal of glaucoma.
[67] R. Klein,et al. Prevalence and risk indicators of visual impairment and blindness in Latinos: the Los Angeles Latino Eye Study. , 2004, Ophthalmology.
[68] C. Margo,et al. AGE-RELATED MACULAR DEGENERATION, ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS, AND SHORT-TERM MORTALITY: A Postmarketing Medication Safety and Surveillance Study , 2011, Retina.
[69] J. Douketis,et al. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. , 2009, Thrombosis research.
[70] S. Gupta,et al. Role of early trabeculectomy in primary open-angle glaucoma in the developing world , 2007, Eye.
[71] C. Puliafito,et al. Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. , 1991, American journal of ophthalmology.
[72] N. Congdon,et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. , 2004, Archives of ophthalmology.
[73] N. Soumittra,et al. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India , 2008, Molecular vision.
[74] George A. Williams,et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. , 2007, Archives of ophthalmology.
[75] Q. Nguyen,et al. Fluocinolone acetonide intravitreal sustained release device – a new addition to the armamentarium of uveitic management , 2007, International journal of nanomedicine.
[76] J. Beiser,et al. The Ocular Hypertension Treatment Study Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals , 2004 .
[77] R. Klein,et al. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[78] D. Kripke,et al. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. , 2004, American journal of ophthalmology.
[79] W. Culbertson,et al. Femtosecond laser-assisted cataract surgery , 2010, Current opinion in ophthalmology.
[80] R. Klein,et al. The Los Angeles Latino Eye Study: design, methods, and baseline data. , 2004, Ophthalmology.
[81] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[82] S. Hahn,et al. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. , 2007, Ophthalmology.
[83] C. Margo,et al. Substance Use Disorder and the Risk of Open-angle Glaucoma , 2011, Journal of glaucoma.
[84] Akira Negi,et al. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. , 2007, American journal of ophthalmology.
[85] A. Coleman,et al. Intraocular Pressure Fluctuation : A Risk Factor for Visual Field Progression at Low Intraocular Pressures in the Advanced Glaucoma Intervention Study , 2008 .
[86] Cynthia Owsley,et al. Impact of cataract surgery on motor vehicle crash involvement by older adults. , 2002, JAMA.
[87] A. Vasavada,et al. Anterior capsule relationship of the AcrySof intraocular lens optic and posterior capsule opacification: a prospective randomized clinical trial. , 2004, Ophthalmology.
[88] N. Powe,et al. Correction: Inaccurate classification and information reported in a study of statin use and sepsis in patients with chronic kidney disease. , 2008, JAMA.
[89] Douglas R. Anderson,et al. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.
[90] W. Smiddy. Economic considerations of macular edema therapies. , 2011, Ophthalmology.
[91] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[92] R. Klein,et al. The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.
[93] D. Friedman,et al. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. , 2004, American journal of ophthalmology.
[94] F. Ferris,et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. , 2007, Archives of ophthalmology.
[95] D. Roth,et al. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. , 2011, Ophthalmology.
[96] Philip J Rosenfeld,et al. Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.